Share Price and Basic Stock Data
Last Updated: December 4, 2025, 2:09 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Alchemist Corporation Ltd operates in the chemicals sector, specifically focusing on inorganic chemicals. The company has faced significant challenges in generating revenue, with reported sales figures consistently standing at ₹0.00 across multiple quarters since June 2022. This stagnation in revenue generation raises concerns about the company’s operational efficiency and market positioning. Over the years, Alchemist’s sales peaked at ₹0.46 Cr in FY 2021, but subsequently declined to negligible levels, reflecting an unsettling trend. The lack of revenue generation has persisted, with the trailing twelve months (TTM) also reporting no sales. This situation suggests that the company may be grappling with fundamental operational issues, making it imperative for investors to scrutinize the underlying causes of this stagnation.
Profitability and Efficiency Metrics
The profitability metrics for Alchemist Corporation reveal a rather bleak picture. The company recorded a net profit of -₹0.31 Cr as of the latest reporting period, indicating ongoing losses. Operating profit margins have also declined, leading to an operating profit of -₹1.31 Cr for FY 2025, a stark contrast to the positive operating profit of ₹0.15 Cr in FY 2021. The interest coverage ratio (ICR) is concerningly low at -3.08x, highlighting that the company struggles to cover its interest obligations with its earnings. Additionally, the return on equity (ROE) stands at a mere 9.02%, which is below the threshold typically considered healthy in the industry. These profitability metrics suggest that while Alchemist has the potential for recovery, it currently appears stretched and may require significant restructuring or strategic changes to improve its financial health.
Balance Sheet Strength and Financial Ratios
Alchemist Corporation’s balance sheet exhibits a mix of strengths and weaknesses. On one hand, the company has no borrowings, which positions it well in terms of financial leverage. This absence of debt could provide a cushion against financial distress. However, the reserves have turned negative, recorded at -₹4.48 Cr in FY 2025, raising concerns about the sustainability of its operations. The price-to-book value ratio of 10.18x suggests that the stock may be overvalued relative to its net assets. Furthermore, the current ratio stands at a comfortable 1.72, indicating adequate liquidity to meet short-term obligations. Yet, with declining equity capital and rising losses, investors may need to question the long-term viability of the company’s financial strategy. The negative reserves and high price-to-book ratio cast a shadow over its overall financial stability.
Shareholding Pattern and Investor Confidence
The shareholding structure of Alchemist Corporation reveals a strong promoter backing, with promoters holding 74.11% of the company. This level of control can instill confidence among investors, as it suggests that the promoters have a vested interest in the company’s recovery and future direction. However, the public float stands at 25.88%, indicating limited participation from institutional investors, which can be a red flag for potential investors. The number of shareholders fluctuated slightly, with 1,601 recorded in the latest period, a decline from earlier in the year. This shrinking base of public shareholders may indicate waning investor interest, further compounded by the company’s financial struggles. The lack of participation from Foreign Institutional Investors (FIIs) also raises questions about the stock’s attractiveness in the broader market context.
Outlook, Risks, and Final Insight
The outlook for Alchemist Corporation is clouded by its persistent operational challenges and negative financial indicators. While the lack of debt provides a buffer, the negative reserves and ongoing losses pose significant risks. Investors should be wary of the company’s ability to turn around its operations in the face of such a bleak revenue landscape. Furthermore, the lack of institutional interest and declining shareholder numbers suggest a potential loss of confidence in the company’s management and strategic direction. However, if the promoters can effectively implement a turnaround strategy, there could be potential for recovery. Investors would do well to monitor developments closely, particularly any strategic initiatives aimed at reviving sales and profitability. Ultimately, while the stock may appear undervalued based on its asset base, the underlying operational issues warrant caution.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 2,964 Cr. | 45.7 | 125/40.8 | 148 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 14.6 Cr. | 29.3 | 47.2/25.8 | 63.7 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 204 Cr. | 261 | 410/238 | 12.2 | 211 | 3.07 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 6,043 Cr. | 489 | 728/408 | 29.5 | 157 | 0.61 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 334 Cr. | 427 | 536/376 | 16.3 | 144 | 0.70 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 4,590.50 Cr | 532.64 | 164.75 | 160.00 | 0.51% | 13.95% | 10.65% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.03 | 0.03 | 0.03 | 0.09 | 0.04 | 0.04 | 0.04 | 0.12 | 0.05 | 0.09 | 0.05 | 1.14 | 0.05 |
| Operating Profit | -0.03 | -0.03 | -0.03 | -0.09 | -0.04 | -0.04 | -0.04 | -0.12 | -0.05 | -0.09 | -0.05 | -1.14 | -0.05 |
| OPM % | |||||||||||||
| Other Income | 0.02 | 0.03 | -0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.43 | 0.03 | 0.03 | 0.03 | 1.03 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.01 | 0.00 | -0.09 | -0.09 | -0.04 | -0.07 | -0.06 | 0.29 | -0.04 | -0.08 | -0.03 | -0.13 | -0.05 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 17.24% | 0.00% | 0.00% | 0.00% | 0.00% | 60.00% | |
| Net Profit | -0.01 | 0.00 | -0.09 | -0.09 | -0.04 | -0.07 | -0.06 | 0.24 | -0.04 | -0.08 | -0.03 | -0.13 | -0.07 |
| EPS in Rs | -0.02 | 0.00 | -0.18 | -0.18 | -0.08 | -0.14 | -0.12 | 0.49 | -0.08 | -0.16 | -0.06 | -0.28 | -0.14 |
Last Updated: August 20, 2025, 12:10 am
Below is a detailed analysis of the quarterly data for Alchemist Corporation Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Expenses, as of Jun 2025, the value is 0.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.14 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 1.09 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.05 Cr.. The value appears strong and on an upward trend. It has increased from -1.14 Cr. (Mar 2025) to -0.05 Cr., marking an increase of 1.09 Cr..
- For OPM %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.03 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 1.03 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.02 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.02 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.05 Cr.. The value appears strong and on an upward trend. It has increased from -0.13 Cr. (Mar 2025) to -0.05 Cr., marking an increase of 0.08 Cr..
- For Tax %, as of Jun 2025, the value is 60.00%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Mar 2025) to 60.00%, marking an increase of 60.00%.
- For Net Profit, as of Jun 2025, the value is -0.07 Cr.. The value appears strong and on an upward trend. It has increased from -0.13 Cr. (Mar 2025) to -0.07 Cr., marking an increase of 0.06 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.14. The value appears strong and on an upward trend. It has increased from -0.28 (Mar 2025) to -0.14, marking an increase of 0.14.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:16 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.34 | 0.00 | 0.40 | 0.34 | 0.34 | 0.46 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.12 | 0.10 | 0.60 | 0.28 | 1.66 | 0.27 | 0.29 | 0.31 | 0.24 | 0.18 | 0.24 | 1.31 | 1.29 |
| Operating Profit | -0.12 | -0.10 | -0.26 | -0.28 | -1.26 | 0.07 | 0.05 | 0.15 | -0.19 | -0.18 | -0.24 | -1.31 | -1.29 |
| OPM % | -76.47% | -315.00% | 20.59% | 14.71% | 32.61% | -380.00% | |||||||
| Other Income | -0.07 | -0.02 | 0.03 | -0.38 | 1.30 | 0.01 | 0.00 | -2.04 | -1.42 | 0.00 | 0.43 | 1.11 | 1.06 |
| Interest | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.07 | 0.03 |
| Depreciation | 0.01 | 0.02 | 0.01 | 0.01 | 0.04 | 0.03 | 0.03 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.21 | -0.15 | -0.25 | -0.67 | -0.01 | 0.05 | 0.02 | -1.92 | -1.62 | -0.18 | 0.12 | -0.27 | -0.26 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | 0.00% | 50.00% | 0.00% | 0.00% | 0.00% | 41.67% | 0.00% | |
| Net Profit | -0.21 | -0.14 | -0.25 | -0.67 | 0.00 | 0.04 | 0.02 | -1.91 | -1.62 | -0.18 | 0.07 | -0.27 | -0.28 |
| EPS in Rs | -0.43 | -0.28 | -0.51 | -1.36 | 0.00 | 0.08 | 0.04 | -3.89 | -3.30 | -0.37 | 0.14 | -0.57 | -0.58 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 33.33% | -78.57% | -168.00% | 100.00% | -50.00% | -9650.00% | 15.18% | 88.89% | 138.89% | -485.71% |
| Change in YoY Net Profit Growth (%) | 0.00% | -111.90% | -89.43% | 268.00% | -150.00% | -9600.00% | 9665.18% | 73.71% | 50.00% | -624.60% |
Alchemist Corporation Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -19% |
| TTM: | -557% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 29% |
| 3 Years: | 35% |
| 1 Year: | 71% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -1% |
| 3 Years: | -1% |
| Last Year: | -3% |
Last Updated: September 5, 2025, 2:11 pm
Balance Sheet
Last Updated: December 4, 2025, 2:20 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 |
| Reserves | 15.29 | 15.11 | 14.84 | 14.16 | 14.17 | 14.22 | 14.25 | 12.34 | 10.72 | 10.54 | 10.95 | -4.36 | -4.48 |
| Borrowings | 0.00 | 0.00 | 0.39 | 0.39 | 0.38 | 0.38 | 0.38 | 0.31 | 0.21 | 0.55 | 0.60 | 0.71 | 0.00 |
| Other Liabilities | 6.89 | 5.61 | 5.68 | 2.57 | 1.71 | 1.75 | 1.68 | 1.79 | 1.63 | 1.61 | 1.34 | 0.07 | 0.19 |
| Total Liabilities | 27.09 | 25.63 | 25.82 | 22.03 | 21.17 | 21.26 | 21.22 | 19.35 | 17.47 | 17.61 | 17.80 | 1.33 | 0.62 |
| Fixed Assets | 15.19 | 15.15 | 15.11 | 15.08 | 15.05 | 15.02 | 14.99 | 14.96 | 14.76 | 14.76 | 14.76 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 4.78 | 4.78 | 4.78 | 2.98 | 2.98 | 2.98 | 2.98 | 2.98 | 1.27 | 1.27 | 1.61 | 0.02 | 0.02 |
| Other Assets | 7.12 | 5.70 | 5.93 | 3.97 | 3.14 | 3.26 | 3.25 | 1.41 | 1.44 | 1.58 | 1.43 | 1.31 | 0.60 |
| Total Assets | 27.09 | 25.63 | 25.82 | 22.03 | 21.17 | 21.26 | 21.22 | 19.35 | 17.47 | 17.61 | 17.80 | 1.33 | 0.62 |
Below is a detailed analysis of the balance sheet data for Alchemist Corporation Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.91 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.91 Cr..
- For Reserves, as of Sep 2025, the value is -4.48 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -4.36 Cr. (Mar 2025) to -4.48 Cr., marking a decline of 0.12 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 0.71 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.71 Cr..
- For Other Liabilities, as of Sep 2025, the value is 0.19 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.07 Cr. (Mar 2025) to 0.19 Cr., marking an increase of 0.12 Cr..
- For Total Liabilities, as of Sep 2025, the value is 0.62 Cr.. The value appears to be improving (decreasing). It has decreased from 1.33 Cr. (Mar 2025) to 0.62 Cr., marking a decrease of 0.71 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.02 Cr..
- For Other Assets, as of Sep 2025, the value is 0.60 Cr.. The value appears to be declining and may need further review. It has decreased from 1.31 Cr. (Mar 2025) to 0.60 Cr., marking a decrease of 0.71 Cr..
- For Total Assets, as of Sep 2025, the value is 0.62 Cr.. The value appears to be declining and may need further review. It has decreased from 1.33 Cr. (Mar 2025) to 0.62 Cr., marking a decrease of 0.71 Cr..
However, the Borrowings (0.00 Cr.) are higher than the Reserves (-4.48 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.12 | -0.10 | -0.65 | -0.67 | -1.64 | -0.31 | -0.33 | -0.16 | -0.40 | -0.73 | -0.84 | -2.02 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 4,573.24 | 2,162.62 | 2,544.26 | 2,254.41 | 0.00 | 0.00 | ||||||
| Inventory Days | 1,233.11 | 0.00 | ||||||||||
| Days Payable | 4,281.35 | |||||||||||
| Cash Conversion Cycle | 1,524.99 | 2,162.62 | 2,544.26 | 2,254.41 | 0.00 | 0.00 | ||||||
| Working Capital Days | 128.82 | 1,213.62 | 1,545.88 | 1,610.29 | -372.93 | -1,825.00 | ||||||
| ROCE % | -0.64% | -0.55% | -1.19% | -1.31% | 0.00% | 0.26% | 0.10% | 0.65% | -1.14% | -1.13% | 1.17% | -2.25% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.55 | 0.13 | -0.37 | -3.29 | -3.89 |
| Diluted EPS (Rs.) | -0.55 | 0.13 | -0.37 | -3.29 | -3.89 |
| Cash EPS (Rs.) | -0.54 | 0.13 | -0.36 | -3.27 | -3.84 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.13 | 2.39 | 1.56 | 1.93 | 4.75 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.13 | 32.28 | 31.45 | 31.82 | 35.11 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.00 | 0.00 | 0.11 | 0.93 |
| PBDIT / Share (Rs.) | -0.41 | 0.36 | -0.36 | 0.22 | 0.31 |
| PBIT / Share (Rs.) | -0.41 | 0.36 | -0.36 | 0.19 | 0.26 |
| PBT / Share (Rs.) | -0.54 | 0.23 | -0.36 | -3.29 | -3.90 |
| Net Profit / Share (Rs.) | -0.54 | 0.13 | -0.36 | -3.29 | -3.89 |
| NP After MI And SOA / Share (Rs.) | -0.56 | 0.13 | -0.36 | -3.29 | -3.89 |
| PBDIT Margin (%) | 0.00 | 0.00 | -12020.00 | 191.22 | 33.58 |
| PBIT Margin (%) | 0.00 | 0.00 | -12020.00 | 172.28 | 28.07 |
| PBT Margin (%) | 0.00 | 0.00 | -12073.33 | -2835.96 | -419.48 |
| Net Profit Margin (%) | 0.00 | 0.00 | -12073.33 | -2834.38 | -418.47 |
| NP After MI And SOA Margin (%) | 0.00 | 0.00 | -11973.33 | -2834.03 | -418.06 |
| Return on Networth / Equity (%) | -49.91 | 5.61 | -23.42 | -170.72 | -81.97 |
| Return on Capital Employeed (%) | -36.01 | 1.13 | -1.16 | 0.61 | 0.73 |
| Return On Assets (%) | -20.94 | 0.37 | -1.01 | -9.25 | -9.88 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.06 | 0.21 | 0.13 |
| Total Debt / Equity (X) | 1.28 | 0.50 | 0.06 | 0.21 | 0.13 |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Current Ratio (X) | 1.72 | 0.73 | 0.71 | 0.84 | 0.74 |
| Quick Ratio (X) | 1.72 | 0.73 | 0.71 | 0.84 | 0.74 |
| Interest Coverage Ratio (X) | -3.08 | 2.75 | -225.38 | 30.28 | 56.89 |
| Interest Coverage Ratio (Post Tax) (X) | -3.08 | 1.98 | -225.38 | 27.53 | 49.26 |
| Enterprise Value (Cr.) | 6.36 | 8.40 | 8.44 | 8.17 | 2.87 |
| EV / Net Operating Revenue (X) | 0.00 | 0.00 | 5623.62 | 143.28 | 6.28 |
| EV / EBITDA (X) | -31.35 | 46.45 | -46.79 | 74.92 | 18.70 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 0.00 | 5618.68 | 139.67 | 5.64 |
| Price / BV (X) | 10.18 | 6.64 | 11.00 | 8.42 | 1.11 |
| Price / Net Operating Revenue (X) | 0.00 | 0.00 | 5716.67 | 140.87 | 5.65 |
| EarningsYield | -0.04 | 0.01 | -0.02 | -0.20 | -0.74 |
After reviewing the key financial ratios for Alchemist Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.55. This value is below the healthy minimum of 5. It has decreased from 0.13 (Mar 24) to -0.55, marking a decrease of 0.68.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.55. This value is below the healthy minimum of 5. It has decreased from 0.13 (Mar 24) to -0.55, marking a decrease of 0.68.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.54. This value is below the healthy minimum of 3. It has decreased from 0.13 (Mar 24) to -0.54, marking a decrease of 0.67.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.13. It has decreased from 2.39 (Mar 24) to 1.13, marking a decrease of 1.26.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.13. It has decreased from 32.28 (Mar 24) to 1.13, marking a decrease of 31.15.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 2. It has decreased from 0.36 (Mar 24) to -0.41, marking a decrease of 0.77.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 0. It has decreased from 0.36 (Mar 24) to -0.41, marking a decrease of 0.77.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.54. This value is below the healthy minimum of 0. It has decreased from 0.23 (Mar 24) to -0.54, marking a decrease of 0.77.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.54. This value is below the healthy minimum of 2. It has decreased from 0.13 (Mar 24) to -0.54, marking a decrease of 0.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.56. This value is below the healthy minimum of 2. It has decreased from 0.13 (Mar 24) to -0.56, marking a decrease of 0.69.
- For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For PBIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For PBT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Net Profit Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 8. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is -49.91. This value is below the healthy minimum of 15. It has decreased from 5.61 (Mar 24) to -49.91, marking a decrease of 55.52.
- For Return on Capital Employeed (%), as of Mar 25, the value is -36.01. This value is below the healthy minimum of 10. It has decreased from 1.13 (Mar 24) to -36.01, marking a decrease of 37.14.
- For Return On Assets (%), as of Mar 25, the value is -20.94. This value is below the healthy minimum of 5. It has decreased from 0.37 (Mar 24) to -20.94, marking a decrease of 21.31.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.28. This value exceeds the healthy maximum of 1. It has increased from 0.50 (Mar 24) to 1.28, marking an increase of 0.78.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Current Ratio (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has increased from 0.73 (Mar 24) to 1.72, marking an increase of 0.99.
- For Quick Ratio (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has increased from 0.73 (Mar 24) to 1.72, marking an increase of 0.99.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -3.08. This value is below the healthy minimum of 3. It has decreased from 2.75 (Mar 24) to -3.08, marking a decrease of 5.83.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -3.08. This value is below the healthy minimum of 3. It has decreased from 1.98 (Mar 24) to -3.08, marking a decrease of 5.06.
- For Enterprise Value (Cr.), as of Mar 25, the value is 6.36. It has decreased from 8.40 (Mar 24) to 6.36, marking a decrease of 2.04.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For EV / EBITDA (X), as of Mar 25, the value is -31.35. This value is below the healthy minimum of 5. It has decreased from 46.45 (Mar 24) to -31.35, marking a decrease of 77.80.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 10.18. This value exceeds the healthy maximum of 3. It has increased from 6.64 (Mar 24) to 10.18, marking an increase of 3.54.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For EarningsYield, as of Mar 25, the value is -0.04. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to -0.04, marking a decrease of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alchemist Corporation Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -36.01% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -49.91% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -3.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.72
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 164.75)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.28
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
Fundamental Analysis of Alchemist Corporation Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | R-4, Unit No. 103, First Floor, New Delhi Delhi 110017 | info@alchemist-corp.com http://www.alchemist-corp.com |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Pooja Rastogi | Managing Director |
| Mr. Kailash | Independent Director |
| Mrs. Meena Rastogi | Non Executive Director |
| Mrs. Sheetal Jain | Non Executive Director |
| Mr. Sanjeev Kumar | Independent Director |
Alchemist Corporation Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹15.11 |
| Previous Day | ₹15.11 |
FAQ
What is the intrinsic value of Alchemist Corporation Ltd?
Alchemist Corporation Ltd's intrinsic value (as of 14 December 2025) is 0.96 which is 96.16% lower the current market price of 25.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 12.3 Cr. market cap, FY2025-2026 high/low of 25.0/10.5, reserves of ₹-4.48 Cr, and liabilities of 0.62 Cr.
What is the Market Cap of Alchemist Corporation Ltd?
The Market Cap of Alchemist Corporation Ltd is 12.3 Cr..
What is the current Stock Price of Alchemist Corporation Ltd as on 14 December 2025?
The current stock price of Alchemist Corporation Ltd as on 14 December 2025 is 25.0.
What is the High / Low of Alchemist Corporation Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Alchemist Corporation Ltd stocks is 25.0/10.5.
What is the Stock P/E of Alchemist Corporation Ltd?
The Stock P/E of Alchemist Corporation Ltd is .
What is the Book Value of Alchemist Corporation Ltd?
The Book Value of Alchemist Corporation Ltd is 0.87.
What is the Dividend Yield of Alchemist Corporation Ltd?
The Dividend Yield of Alchemist Corporation Ltd is 0.00 %.
What is the ROCE of Alchemist Corporation Ltd?
The ROCE of Alchemist Corporation Ltd is 7.45 %.
What is the ROE of Alchemist Corporation Ltd?
The ROE of Alchemist Corporation Ltd is 9.02 %.
What is the Face Value of Alchemist Corporation Ltd?
The Face Value of Alchemist Corporation Ltd is 10.0.